•  
  •  
  •  
  •  

2026-02-10 04:30:44

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • UVS Hospitality and Services Ltd announces strategic fundraise and acquisition of Calcio Restaurants in major Expansion Move
  • Cholamandalam Financial Holdings Ltd 9M FY26 consolidated PAT at Rs. 3860 crores
  • Strategic Boost to Atmanirbharta in Shipbuilding as GRSE and HSL Sign MoU
  • India needs nearly 2,000 Exploration Licenses in oil and gas to become energy secured says, Vedanta Group Chairman
  • Nifty steadies after gap-up, recovery attempts gain traction

Keywords Selected:  Formulation

Stock Report

  • Akums introduces enhanced Gabapentin ER Formulation powered by RetenEx Technology for PHN Management
  • Eiko LifeSciences Ltd to acquire 51% stake in SSM Formulations Pvt Ltd
  • Sun Pharma Laboratories Ltd to set up greenfield formulations facility in MP
  • Glenmark Pharmaceuticals Ltd update on USFDA PAI at Chhatrapati Sambhajinagar Facility
  • Syncom Formulations India Ltd acquires commercial property
  • Closure of Remote Regulatory Assessment by the USFDA at Matoda, Gujarat facility
  • India Pesticides Limited commissions expanded capacity of formulation plant
  • Syncom Formulations India Ltd commissions solar rooftop project
  • Wanbury Limited launching two new products, Formulation - Branded Hematinic Iron tablets, WANBURY C-RED and API- KETAMINE HYDROCHLORIDE
  • Jubilant Cadista Pharmaceuticals Inc., USA's facility receives EIR from USFDA
  • USFDA inspection of J B CHemicals and Pharmaceuticals Ltd's manufacturing facility - T20 at Panoli, Gujarat
  • Jubilant Cadista Pharmaceuticals Inc receives 5 observations from USFDA for Salisbury facility
  • Alembic Pharmaceuticals Ltd's Oncology facility successfully completes USFDA inspection
  • US FDA inspection at Alembic Pharmaceuticals Limited' Oral Solid Formulation Facility at Panelav
  • Torrent Pharmaceuticals Ltd receives Form 483 from USFDA for Formulation Facility
  • Wanbury Limited appoints Mr. Pradeep Patni as CEO of India Formulation Business
  • Strides Pharma Science Ltd gets EIR from USFDA on continued GMP status for the facility in Alathur, Chennai
  • Unichem Laboratories Ltd gets 5 observations from USFDA for Goa formulation facility
  • Alembic Pharmaceuticals Limited receives EIR from USFDA for Oncology Formulation facility
  • Eris Lifesciences acquires the commercial rights to Biocon Biologics' India Branded Formulations business
  • APL Healthcare Ltd updates on inspection
  • Zydus receives WHO prequalification for Miltefosine formulation and API
  • Suven Pharmaceuticals Ltd's API and Forumulations facilities complete USFDA inspection successfully
  • Concord Biotech Ltd receives GMP certificate from Kenya regulator

Latest Post

  • UVS Hospitality and Services Ltd announces strategic fundraise and acquisition of Calcio Restaurants in major Expansion Move
  • Cholamandalam Financial Holdings Ltd 9M FY26 consolidated PAT at Rs. 3860 crores
  • Strategic Boost to Atmanirbharta in Shipbuilding as GRSE and HSL Sign MoU
  • India needs nearly 2,000 Exploration Licenses in oil and gas to become energy secured says, Vedanta Group Chairman
  • Nifty steadies after gap-up, recovery attempts gain traction


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025